Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2007-07-17FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) from AbbVie, resulting in changes to the product labeling. Paricalcitol i…
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) [Phase 3]
This Phase 3 trial evaluates the safety and efficacy of Zemplar (paricalcitol) capsules given three times weekly in adults with chronic kidn…
-
CLINICAL_TRIALS trial_result · 2006-08-02Clinical Trial Update: Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis [Phase 4]
Phase 4 clinical trial evaluating Zemplar (paricalcitol) injection for safety and effectiveness in decreasing iPTH levels in pediatric patie…
-
CLINICAL_TRIALS trial_result · 2006-08-02Clinical Trial Update: Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium [Phase 4]
A phase 4 clinical trial evaluated the effects of Zemplar (paricalcitol) injection and Calcijex (calcitriol) on intestinal calcium absorptio…
-
FDA approval · 2006-07-03FDA Approved: CALCITRIOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Calcitriol from Hikma Pharmaceuticals USA Inc., updating the approval status for this generi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.